Oncogenic mechanisms of Evi-1 protein
โ Scribed by Hisamaru Hirai; Koji Izutsu; Mineo Kurokawa; Kinuko Mitani
- Book ID
- 105994697
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 202 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The AML1/EVI-1 chimeric gene is generated by the t(3;21)(q26;q22) translocation and plays a pivotal role in progression of hematopoietic stem cell malignancies such as chronic myelocytic leukemia and myelodysplastic syndrome. In AML1/EVI-1, an N-terminal half of AML1 including a runt homology domain
## Abstract Accumulating evidence demonstrates that PKCฮน is an oncogene and prognostic marker that is frequently targeted for genetic alteration in many major forms of human cancer. Functional data demonstrate that PKCฮน is required for the transformed phenotype of lung, pancreatic, ovarian, prostat
## Abstract Cyclinโdependent kinase 2 (Cdk2) phosphorylates Thr320 of protein phosphatase 1ฮฑ (PP1ฮฑ) in late G~1~, thereby inhibiting its activity. Phosphorylationโresistant PP1ฮฑT320A, acting as a constitutively active (CA) mutant, causes a late G~1~ arrest by preventing the phosphorylation and inac